Clinical Updates in HER2+ mBC with ASCO coverage

 

University of Colorado Cancer Center
E

Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Combination in Patients With HR+/HER2+ MBC

By University of Colorado Cancer Center FEATURING Elena Shagisultanova
By University of Colorado Cancer Center FEATURING Elena Shagisultanova
222 views
June 23, 2021
0 Comments
Login to view comments. Click here to Login
Clinical Updates in HER2+ mBC with ASCO coverage
05:41
Alicia Okines

2021 ASCO Updated Results of HER2CLIMB Study: Tucatinib vs. Placebo …

20:20
Penn Medicine Abramson Cancer Center

2021 Penn Medicine HER2+ MBC Updates

Feat. S. Bhattacharya
11:06
Total Health

Advances in HER2+ MBC: Management of CNS Metastases

Feat. T. Traina, L. Carey
09:00
Cleveland Clinic's Breast Cancer Update: Review of Breast Cancer Symposia

Overview of Available Treatment Options in HER2+ MBC: Tucatinib Comb…

Feat. J. Abraham
17:39
Virtual West Oncology Conference

2021 Update on Breast Cancer Brain Metastases: Current Treatment Opt…

Feat. L. Schwartzberg
14:39
University of Kansas Cancer Center Post San Antonio Review

What's New in HER2+ MBC Targeted Therapy: Efficacy Analysis of …

Feat. H. McArthur
07:59
Azadeh Nasrazadani

Current Data on the Reduction in Risk of Developing New Brain Lesion…

06:50
Akshjot Puri

2021 ASCO Updates on Systemic Chemotherapy in Patients With Brain On…

07:27
Jennifer Plichta

2021 ASCO Highlights on the Survival Among Patients With Untreated M…

19:16
Sarah Sammons

2021 ASCO Update: Impact of Extracranial Disease Status on Survival …

07:12
Rachel Wuerstlein

ASCO 2021 Updates on the Safety of T-DM1 in Patients With HER2+ Loca…

10:50
University of Colorado Cancer Center

Surveying Efficacy Data of Tucatinib, Palbociclib and Letrozole Comb…

Feat. E. Shagisultanova
05:23
Virtual Evolution: A Conference for Women by Women

Expert Panel Discussion on HER2+ MBC: What Are the RT Options for Br…

Feat. J. Crozier, M. Lima, R. L. Mahtani, K. Mirabeau-Beale, M. Rueda-Lara
18:14
University of Colorado Cancer Center

Overview of HR+/HER2+ BC: Prevalence in the US, Subtypes, and Design…

Feat. E. Shagisultanova
24:44
Total Health

HER2+ BC Panel Discussion: Advances in Treatment and Sequencing of T…

Feat. L. Kennedy, B. Patterson, J. Petruney